Palvella Therapeutics (PVLA) Preferred Dividend Payments (2024)
Palvella Therapeutics' (PVLA) quarterly Preferred Dividend Payments came in at -$582000.0 in Q4 2024, down 400.0% on a QoQ basis from $194000.0 in Q3 2024.
Palvella Therapeutics (PVLA) Preferred Dividend Payments (2024) Analysis & Trends
Palvella Therapeutics (PVLA) has 1 years of Preferred Dividend Payments data on file, last reported at -$582000.0 in Q4 2024.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to -$582000.0 in Q4 2024; TTM through Sep 2025 was -$582000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $776000.0, changed N/A from the prior year.
- Preferred Dividend Payments for Q4 2024 stood at -$582000.0, down from $194000.0 in the prior quarter.
- Over the last five years, Preferred Dividend Payments for PVLA reached as high as $194000.0 in Q1 2024 and fell as low as -$582000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -582,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 194,000.00 |